Licensing, Acquisitions, and Other Arrangement- Acquisitions of Apogee Therapeutics, Inc. (Details) - Apogee Therapeutics, Inc $ / shares in Units, $ in Billions |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
USD ($)
$ / shares
| |
| Business Acquisition [Abstract] | |
| Total consideration | $ | $ 10.9 |
| Business Combination, Price Per Share | $ / shares | $ 135.11 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Per share price of saleable stock paid or offered to be paid by acquirer in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|